ENTITY

Portola Pharmaceuticals (PTLA US)

Analysis

Health Care • United States

Portola Pharmaceuticals, Inc. provides specialty pharmaceutical products. The Company offers novel therapeutics for thrombosis, hematologic disorders, and inflammation. Portola Pharmaceuticals serves customers in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00